however, timed too late in the afternoon, a nap could interfere with falling asleep at bedtime
What about taking both compounds for months or years
Chen B, Yu X, Horvath-Diano C, Ortuo MJ, Tschp MH, Jastreboff AM, Schneeberger M (2024) GLP-1 programs the neurovascular landscape
When deciding which drug is best, a healthcare provider may consider other factors such as drug administration, concurrent heart disease, price, or the severity of the diabetes diagnosis
Rushing the injection
2,3 The REDEFINE 1 trial found that when evaluating the treatment effect regardless of whether patients stayed on treatment, those treated with CagriSema achieved weight loss of 20.4% (from an average baseline body weight of 236 lb.) at 68 weeks versus 3.0% (from an average baseline body weight of 235 lb.) for the placebo group which was statistically significant